Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Gyorgi Keri of Vichem Chemie Research to Speak at Protein Kinases Mtg on May 8-9, 2014 in Berlin, Germany - Gyorgi Keri, Professor, CEO & CSO at Vichem Chemie Research Ltd will give a presentation titled “Developing Kinase Inhibitors for Personalized Therapy,” at the Protein Kinases in Drug Discovery Conference Europe in Berlin, Germany on May 8-9, 2014 by GTC
Gyorgi Keri of Vichem Chemie Research to Speak at Protein Kinases Mtg on May 8-9, 2014 in Berlin, Germany

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2013/12/15 - Gyorgi Keri, Professor, CEO & CSO at Vichem Chemie Research Ltd will give a presentation titled “Developing Kinase Inhibitors for Personalized Therapy,” at the Protein Kinases in Drug Discovery Conference Europe in Berlin, Germany on May 8-9, 2014 by GTC.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Gyorgi Keri is the founder of Vichem Chemie Res. Ltd and is a Professor at Semmelweis University. He got his PhD from biochemistry in Budapest, and was post doc. at University of California, San Francisco.

He has been working together with Professor Axel Ullrich (Max Planck Institute) for more than 25 years on developing kinase inhibitors. He was advisor and collaborative partner of SUgen Inc. from 1992 to 1999 and Axxima Pharmaceuticals from 1999 to 2005.

He has been involved in the development of several kinase inhibitors which have been licensed for external partners. He also developed the Nested Chemical Library™ (NCL) technology, based on a knowledge based approach where focused libraries of kinase inhibitors around more than 600 scaffolds are used for hit finding and to generate pharmacophore models.

Using the NCL™ kinase inhibitor library, Vichem has developed, and will further develop, kinase inhibitors which kill more than 95% of certain cancer cells (including cancer stem cells). The goal is to provide a personalized therapy and molecular diagnostic protocol to select who will respond to a particular cancer stem cell killing drug.

The Protein Kinases in Drug Discovery Conference Europe, to be held on May 8-9, 2014, in Berlin, Germany, will be a premier conference that will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on drug discovery aspects within the protein kinases field. A balance of both academic and industry experts will facilitate discussion on validation of novel drug targets, current progress in drug design, kinases inhibitor development, and preclinical models and clinical development.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Gyorgi Keri of Vichem Chemie Research to Speak at Protein Kinases Mtg on May 8-9, 2014 in Berlin, Germany

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today